- Home
- OPK vs BCSF Comparison
OPK vs BCSF Comparison
Compare OPK & BCSF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPK
- BCSF
- Stock Information
- Founded
- OPK 2007
- BCSF 2015
- Country
- OPK United States
- BCSF United States
- Employees
- OPK N/A
- BCSF N/A
- Industry
- OPK Biotechnology: Pharmaceutical Preparations
- BCSF Finance/Investors Services
- Sector
- OPK Health Care
- BCSF Finance
- Exchange
- OPK Nasdaq
- BCSF Nasdaq
- Market Cap
- OPK 1.0B
- BCSF 1.1B
- IPO Year
- OPK 1995
- BCSF 2018
- Fundamental
- Price
- OPK $1.47
- BCSF $17.36
- Analyst Decision
- OPK Strong Buy
- BCSF Hold
- Analyst Count
- OPK 3
- BCSF 4
- Target Price
- OPK $2.75
- BCSF $16.75
- AVG Volume (30 Days)
- OPK 2.9M
- BCSF 194.2K
- Earning Date
- OPK 02-25-2025
- BCSF 02-25-2025
- Dividend Yield
- OPK N/A
- BCSF 10.35%
- EPS Growth
- OPK N/A
- BCSF N/A
- EPS
- OPK N/A
- BCSF 1.99
- Revenue
- OPK $711,408,000.00
- BCSF $294,257,000.00
- Revenue This Year
- OPK N/A
- BCSF N/A
- Revenue Next Year
- OPK $0.00
- BCSF N/A
- P/E Ratio
- OPK N/A
- BCSF $8.75
- Revenue Growth
- OPK N/A
- BCSF 3.17
- 52 Week Low
- OPK $0.86
- BCSF $14.78
- 52 Week High
- OPK $1.76
- BCSF $17.97
- Technical
- Relative Strength Index (RSI)
- OPK 44.04
- BCSF 53.36
- Support Level
- OPK $1.44
- BCSF $16.79
- Resistance Level
- OPK $1.55
- BCSF $17.58
- Average True Range (ATR)
- OPK 0.06
- BCSF 0.27
- MACD
- OPK -0.00
- BCSF -0.02
- Stochastic Oscillator
- OPK 33.33
- BCSF 48.31
About OPK OPKO Health Inc.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Opko's diagnostics business includes a core genetic testing operation. It has a development and commercial supply pharmaceutical company, as well as a world supply-chain operation and holding company in Ireland. It also owns a specialty active pharmaceutical ingredients manufacturer in Israel. It operates in two segments Diagnostics and Pharmaceuticals.
About BCSF Bain Capital Specialty Finance Inc.
Bain Capital Specialty Finance Inc is an externally managed, closed-end, non-diversified management investment company. The company's objective is to provide risk-adjusted returns and current income to investors by investing predominantly in middle-market companies with between $10.0 million and $150.0 million in annual EBITDA. Its portfolio of investments includes, First Lien Senior Secured Loan, Preferred Equity, Equity Interest, and Second Lien Senior Secured Loan among others.